NCT06123455 - Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Gastric Cancer

Interventions

DIETARY_SUPPLEMENT

Taurine

Taurine supplementation in capsules of 1.0 gram of taurine powder. Dosage: 2.0 gram/day. Frequency: 2 time/day.

BIOLOGICAL

Sintilimab

DRUG

XELOX regimen

Oxaliplatin + capecitabine

DRUG

SOX regimen

Oxaliplatin + S-1 (tegafur/gimeracil/oteracil potassium)

DRUG

FOLFOX regimen

Oxaliplatin + leucovorin + fluorouracil

Trial Locations (1)

RECRUITING

Tang-Du Hospital, Xi'an

All Listed Sponsors

lead

Tang-Du Hospital

OTHER